Next Article in Journal
The Key Role of Mitochondrial Function in Health and Disease
Previous Article in Journal
Spatial Distribution and Antioxidant Activity of Extracts from Citrus Fruits
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antioxidants
Volume 12
Issue 4
10.3390/antiox12040783
antioxidants-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Effect of Chronically Suppressed Plasma Angiotensin II on Regulation of the CYP4A/20-HETE Pathway in the Dahl Salt-Sensitive Rat

by
Kathleen Lukaszewicz
1,
John R. Falck
2 and
Julian Lombard
3,*
1
Department of Physical Therapy, Marquette University, Milwaukee, WI 53233, USA
2
Department of Biochemistry, University of Texas Southwestern Medical School, Dallas, TX 75390, USA
3
Department of Physiology, Medical College of Wisconsin, Milwaukee, WI 53226, USA
*
Author to whom correspondence should be addressed.
Antioxidants 2023, 12(4), 783; https://doi.org/10.3390/antiox12040783
Submission received: 23 February 2023 / Revised: 16 March 2023 / Accepted: 21 March 2023 / Published: 23 March 2023
(This article belongs to the Section Health Outcomes of Antioxidants and Oxidative Stress)
Browse Figures
Review Reports Versions Notes

Abstract

:
In Dahl salt-sensitive (SS) rats, impaired vascular relaxation can be restored by: (1) minipump infusion of a low (sub-pressor) dose of angiotensin II (ANG II) to restore physiological levels of plasma ANG II, (2) inhibition of 20-HETE production, and (3) introgression of a normally functioning renin allele from the Brown Norway rat (SS-13BN consomic rat). Unlike SS rats, SS-13BN rats have normal levels of ANG II on a normal-salt diet and suppressed ANG II on a high-salt (HS) diet. This study tested whether chronically low ANG II levels in SS rats upregulate cytochrome P450-4A (CYP4A) increasing the production of the vasoconstrictor 20-HETE. Although salt-induced suppression of ANG II levels increased reactive oxygen species (ROS) in basilar arteries from SS-13BN rats in previous studies, this study showed no change in vascular 20-HETE levels in response to ANGII suppression. CYP4A inhibition significantly reduced vascular ROS levels and restored endothelium-dependent relaxation in response to acetylcholine in the middle cerebral artery (MCA) of SS rats and HS-fed SS-13BN rats. These data demonstrate that both the renin–angiotensin system and the CYP4A/20-HETE pathway play a direct role in the vascular dysfunction of the Dahl SS rat but are independent of each other, even though they may both contribute to vascular dysfunction through ROS production.

1. Introduction

The SS rat has a low-renin salt-sensitive form of hypertension—the type of hypertension most prevalent in the African American population [1,2]. Human subjects [3,4] and animal models [5,6] with this form of hypertension have a reduced activity of the renin–angiotensin system leading to chronic suppression of plasma angiotensin II (ANG II) levels. Previous studies in our laboratory have shown that chronic exposure to low levels of circulating angiotensin II (ANG II) during elevated dietary salt intake leads to impaired vascular relaxation [7,8,9,10]. This is accompanied by reduced nitric oxide (NO) levels [10,11,12], elevated superoxide (O2●−) levels [10,11,12], and impaired endothelial Ca2+ signaling [12]. ANG II suppression leads to vascular oxidative stress by compromising the antioxidant defense mechanisms by suppressing Cu/Zn SOD expression [13,14,15]. All of these defects can be ameliorated by chronic intravenous (i.v.) infusion of a low (sub-pressor) dose of ANG II that restores normal circulating ANG II levels [7,8,9,10].
In a similar fashion, SS rats have an impaired ability to regulate their plasma renin activity (PRA) [16] and exhibit severe endothelial dysfunction and impaired vascular relaxation, even when they are normotensive and maintained on a normal-salt (NS; 0.4% NaCl) diet [17,18]. Impaired vascular relaxation in SS rats fed a NS diet can be restored not only by chronic i.v. infusion of a sub-pressor dose of ANG II to restore normal plasma levels of ANG II [7,8,19], but also by introgressing chromosome 13 from the Brown Norway (BN) rat carrying a normally functioning renin allele into the SS genetic background (SS-13BN consomic rats) [17,20]. The SS-13BN consomic rat, sharing 98% homology to the genome of the Dahl SS rat, exhibits normal circulating levels of ANG II on a NS diet and provides an excellent comparison for the SS rat [17].
20-HETE, a vasoconstrictor metabolite of arachidonic acid that is formed through the action of cytochrome P450-4A (CYP4A) enzymes in the vascular smooth muscle cells, has been associated with hypertension and vascular dysfunction. We recently found that a high-salt (HS; 4.0% NaCl) diet up-regulates the expression of mRNA and protein of CYP4A in the mesenteric resistance arteries of Sprague Dawley (S-D) rats [21] and cremasteric arterioles of SS rats [22]. CYP4A inhibition with dibromododecenyl methylsulfimide (DDMS) restores impaired vascular relaxation in mesenteric arteries from S-D rats fed a HS diet [21] and abolishes the potentiated vasoconstrictor response to elevated PO2 in cremasteric arterioles from SS rats [22].
Thus, it appears that two different mechanisms (an activated CYP4A/20-HETE system and chronically suppressed plasma ANG II levels) can both explain the impaired vascular relaxation in NS-fed SS rats and other strains fed a HS diet. The question is whether these two systems are working in parallel to one another or whether they are in some way interrelated. Of particular interest is the question of whether there is a relationship between circulating ANG II levels and regulation of the CYP4A/20-HETE pathway. The present study evaluated the unifying hypothesis that upregulation of CYP4A enzyme expression and 20-HETE production in cerebral resistance arteries of SS rats fed NS diets and SS-13BN rats fed HS diets are due to chronic exposure to low levels of ANG II.

2. Materials and Methods

2.1. Experimental Groups

Eight- to twelve-week-old male SS-13BN consomic rats (30 animals used in total for all experiments) and Dahl SS rats (25 animals used in total for all experiments) from colonies maintained at the Medical College of Wisconsin were used for these studies. Following weaning, the SS-13BN rats were maintained on a normal-salt diet (0.4% NaCl; Dyets, Inc., Bethlehem, PA, USA) or switched to a high-salt (4.0% NaCl; Dyets, Inc.) diet for 3 days to suppress plasma ANG II levels. SS rats were implanted with an osmotic minipump to deliver either isotonic saline vehicle or angiotensin II (100 ng/kg/min). This dose of ANG II has previously been shown to be sufficient to restore vascular function in SS rats, but not high enough to cause the deleterious effects of elevated ANG II on endothelium-dependent vasodilation [15,23]. Following implantation of the osmotic minipumps, the animals were placed on a high-salt diet for 3 days prior to individual experimental protocols and given water ad libitum. The Medical College of Wisconsin IACUC approved all protocols.

2.2. Isolated Vessel Experiments

Animals were anesthetized with an intramuscular injection containing (in mg/kg) ketamine (75.0), acepromazine (2.5), and anased (10.0). The brain was removed, and the middle cerebral artery was isolated, cannulated with micropipettes and perfused and superfused with physiological salt solution (PSS) equilibrated with a 21% O2, 5% CO2, and 74% N2 gas mixture, as previously described [24]. The artery was maintained at a transmural pressure of 80 mmHg and the vessel diameters were measured via video microscopy.
After the 60 min control equilibration period, vessel responses to the endothelium-dependent dilator acetylcholine (ACh; 10−10–10−5 M) and the endothelium-independent nitric oxide donor sodium nitroprusside (SNP; 10−12–10−4 M) were determined. The vessels were then incubated for 30 min in the presence of the CYP4A enzyme inhibitor DDMS (50 µM) and the responses to ACh and SNP were repeated. Another group of vessels was incubated for 30 min without the inhibitor and responses to vasodilator stimuli were measured as a time control.
In a second series of experiments, the cytochrome P450 inhibitor DDMS (50 µM) was added to the perfusate and superfusate for the final 30 min of the control equilibration period and responses of the arteries to the vasodilator agonists were recorded before and after incubation with L-NAME (100 µM) or indomethacin (1 µM) for 30 min in the perfusate and superfusate. The responses to ACh were also determined in a separate group of vessels after a 30 min equilibration period without the inhibitor as a time control.
The maximum diameter of the isolated vessel was measured at the conclusion of the experiment. Hydrogen peroxide (H2O2; 1.76 mM) was added to the superfusate to induce maximal dilation. The percent of active resting tone (%) was determined as [(Dmax − Drest) / Dmax] × 100, where Dmax is the maximum diameter in the presence of H2O2 and Drest is the resting control diameter.

2.3. 20-HETE Production in Cerebral Arteries

Vascular 20-HETE production was measured in cerebral arteries from NS- or HS-fed SS-13BN consomic rats and in arteries from ANG II- or saline-infused HS-fed SS rats as previously described [25]. In those experiments, the cerebral circulation was flushed with ice-cold Tyrode’s solution and the cerebral arteries were carefully removed and incubated in potassium phosphate buffer containing 2 mM NADPH, 40 μM cold arachidonic acid, and 2 μM indomethacin for a 1.0 mL total reaction volume at 37 °C and equilibrated with 100% O2 for 90 min to produce 20-HETE. The vessels were homogenized and 30 μL of the homogenate was used to measure protein concentration using a modified Bradford method. 20-HETE was extracted from the remaining homogenate using ethyl acetate, and the organic layer was dried under nitrogen. The samples were reconstituted in methanol and 20-HETE was measured using liquid chromatography-mass spectrometry (LC-MS) [25].

2.4. Dihydroethidium Fluorescence

Dihydroethidium (DHE) was utilized to assess the vascular reactive oxygen species (ROS) levels in basilar arteries [15]. Basilar arteries were used as a surrogate for MCA because both vessels have a NO-dependent dilation response to ACh, but the increased size of the basilar artery improves vascular imaging [15]. The basilar artery was incubated for 1 h in PSS warmed to 37 °C. DHE (5 μmol/L) was added to the incubating solution for the final 15 min. The arteries were sliced into 10 µm transverse sections and imaged with a Nikon Eclipse TS100 microscope (Nikon, Tokyo, Japan) equipped with a ×20 objective, a 540 nm excitation filter, a 605 nm emission filter (Chroma Technology Corp., Bellows Falls, VT, USA), and QImaging Regiga-2000R digital camera (Surrey, BC, Canada). Multiple images of each artery were quantified using ImageJ software and background fluorescence was subtracted from the fluorescence value of the imaged vessel [15].

2.5. Statistical Analysis

The data are presented as mean ± SEM. An unpaired Student’s t-test was used for comparisons between two groups. A one-way analysis of variance (ANOVA) was used to compare the concentration–response curves between multiple groups at each concentration. Following the ANOVA, the differences between individual groups were evaluated using a post hoc Student–Newman–Keuls test. The differences between groups were considered significant at p < 0.05.

3. Results

3.1. Vascular Responses

3.1.1. Vessel Diameter and Active Tone in SS-13BN Consomic Rats and Dahl SS Rats Receiving Osmotic Minipumps

Maximum diameter, resting diameter, and active resting tone in isolated middle cerebral arteries (MCA) from SS-13BN consomic rats and HS-fed SS rats receiving osmotic minipumps are presented in Table 1 and Table 2, respectively. The active tone in arteries from SS-13BN consomic rats was unaffected by dietary salt or incubation with inhibitors (DDMS, L-NAME, indomethacin) (Table 1) and there was no effect of incubation with these inhibitors on active tone in SS rats receiving either ANG II or saline infusion (Table 2). Therefore, any effects on the magnitude of vascular relaxation responses in the present study did not result from initial differences in resting tone due to pre-existing constriction of the artery. There was a reduced resting diameter in SS + ANG II when incubated with L-NAME, likely a result of the loss of ANG II-dependent NO preservation and the vasoconstrictor effect of ANG II acting through the AT1 receptor, which did not change the conclusions drawn from the data collected since it did not alter the % active tone.

3.1.2. Effect of Chromosome 13 Substitution on Responses of MCA to Acetylcholine (ACh)

Figure 1A summarizes the response to ACh in the MCA from SS-13BN consomic rats. When the animals were fed a NS diet to maintain normal plasma ANG II levels [17], the MCA dilated in response to ACh and the addition of DDMS did not augment the dilation. By contrast, the MCA from SS-13BN rats failed to respond to ACh when plasma ANG II levels were suppressed with a high-salt diet. Addition of DDMS to inhibit CYP4A enzymes fully restored ACh-induced dilation to NS-control values in the arteries of HS-fed SS-13BN rats. L-NAME abolished the response to ACh in the MCA from NS-fed SS-13BN and in DDMS-treated MCA from high-salt-fed SS-13BN consomic rats (Figure 1B), showing that vascular relaxation to ACh in both those groups is nitric oxide-dependent.
The MCA from SS-13BN consomic rats fed either a NS or HS diet dilated normally to the exogenous nitric oxide donor, sodium nitroprusside. Addition of DDMS to the tissue bath did not affect this dilation (Figure 1C), indicating that the vascular dysfunction in SS-13BN rats fed a HS diet is due to a loss of nitric oxide bioavailability, rather than a failure of the vascular smooth muscle cells to respond to NO.

3.1.3. Effect of Low-Dose ANG II Infusion on Vascular Responses in MCA from Dahl SS Rats

Figure 2A summarizes the response to ACh in MCA from ANG II-infused SS rats versus saline-infused SS rats fed a HS diet. When circulating ANG II levels were elevated by delivering a sub-pressor dose of ANG II via an osmotic minipump, ACh caused vascular relaxation with no additional benefit of acute treatment with DDMS. Saline-treated SS rats failed to respond to ACh, but the addition of DDMS to inhibit CYP4A restored ACh-induced vasodilation in arteries from those animals. Similar to our findings in the SS-13BN consomic rats, these data indicate that maintenance of normal circulating levels of ANG II leads to improved vascular relaxation.
The vascular response to ACh in the MCA from both ANG II-infused SS rats and DDMS-treated MCA from saline-treated SS rats utilizes nitric oxide, as ACh-induced dilation in both groups was eliminated by co-incubation with L-NAME and was unaffected by indomethacin in the tissue bath (Figure 2B). The MCA from SS rats receiving either ANG II or saline ± DDMS responded normally to sodium nitroprusside (Figure 2C), demonstrating that the vascular dysfunction in the SS rat is due to loss of NO bioavailability, rather than reduced responsiveness of the vascular smooth muscle cells to NO per se.

3.2. Vascular 20-HETE Production

3.2.1. 20-HETE Levels in Cerebral Arteries of SS-13BN Rats

The production of 20-HETE by CYP4A enzymes (Figure 3A) in cerebral arteries from SS-13BN consomic rats were unaffected by dietary salt content. These data do not support the hypothesis that ANG II suppression is causing an increase in 20-HETE production in the SS rat by CYP450 enzymes. As such, these findings are contrary to the vascular data presented in Figure 1 demonstrating that CYP4A inhibition restores vascular relaxation in response to acetylcholine in HS-fed SS-13BN consomic rats. Because elevated dietary salt intake does not affect vascular 20-HETE production, a high-salt diet must be indirectly unveiling a role for the CYP4A/20-HETE pathway in vascular dysfunction in SS-13BN consomic rats. A likely candidate for this indirect effect is the HS-induced elevation of tissue reactive oxygen species.

3.2.2. 20-HETE Levels in Cerebral Arteries from Saline- or ANGII-Infused Dahl SS Rats

Figure 3B compares 20-HETE production in cerebral arteries from SS rats receiving either saline or a low-dose ANG II infusion. ANG II infusion had no effect on 20-HETE production in the cerebral arteries of HS-fed SS rats. Similar to our findings in SS-13BN consomic rats, these data indicate that CYP4A regulation is independent of changes in circulating ANG II levels, because neither salt-induced ANG II suppression in the SS-13BN consomic rat nor artificial ANG II supplementation in the low-renin SS rat altered cerebral vascular 20-HETE production.

3.3. Dihydroethidium (DHE) Fluorescence

Vascular Reactive Oxygen Species Evaluated by DHE Fluorescence

Figure 4 summarizes the levels of reactive oxygen species (ROS) in arteries from SS-13BN consomic rats fed a NS or HS diet with and without inhibition of CYP4A enzymes with DDMS. Restoring circulating ANG II levels by introgression of Brown Norway chromosome 13 (SS-13BN consomic rat) reduced vascular ROS to the same extent as incubating vessels from HS-fed SS-13BN with the CYP4A inhibitor DDMS. These data demonstrate a common mechanism for the reduction of vascular ROS levels between these two independent pathways (restoration of normal ANG II levels and inhibition of the CYP4A pathway), ultimately resulting in the restoration of vascular function.

4. Discussion

The present study sought to evaluate the possible contribution of the CYP4A/20-HETE pathway to the vascular dysfunction in the SS rat. In Sprague Dawley (S-D) rats, high-salt-induced suppression of the renin–angiotensin system (RAS) is accompanied by a significant elevation of CYP4A protein expression in mesenteric arteries [21] suggesting that the RAS is a potential pathway to exert regulatory control over cytochrome P450-4A (CYP4A). Based on those initial studies, we hypothesized that there is a negative feedback loop whereby the renin–angiotensin system exerts a chronic inhibitory effect over CYP4A/20-HETE expression. Consistent with this hypothesis, the elevated CYP4A protein observed in mesenteric arteries from S-D rats fed high-salt diet has been shown to contribute to vascular dysfunction [21], possibly as an indirect effect of suppressed plasma ANG II.
The existence of a consomic panel of SS rats with individual chromosomes from the normotensive Brown Norway (BN) rat introgressed into the Dahl SS genetic background [20] provides a unique opportunity to evaluate the interrelationship between the renin–angiotensin system and the CYP4A/20-HETE pathway in the SS rat. The genetic homogeneity of the consomic animal model has reduced phenotypic noise, making it easier to detect the possible contribution of individual chromosomes to functional differences in complex, multifactorial diseases such as hypertension. The SS-13BN consomic rat has chromosome 13 from the BN rat introgressed on the SS genetic background. This strain is more than 98% identical to the SS rat genetically [20], but has a normally functioning renin–angiotensin system, resulting in physiologic levels of plasma ANG II when the animals are fed a normal-salt diet and suppression of plasma ANG II following ingestion of elevated dietary sodium [20].
In the present study, the vascular responses to ACh were intact in SS-13BN consomic rats fed a NS diet. In agreement with previously published reports [26,27], this is presumably due to restoration of the normal function of the renin–angiotensin system, which would produce physiological levels of circulating ANG II. In the present study, endothelium-dependent vascular relaxation in response to ACh was abolished when the SS-13BN consomic rats were fed a high-salt diet for three days to suppress the renin–angiotensin system. Previously published reports on the effect of chronic exposure to low levels of ANG II on antioxidant capabilities, as observed in HS-fed S-D rats [28] and NS-fed SS rats [15], describe reduced expression of Cu/Zn-SOD (and possibly other antioxidant enzymes), resulting in reduced antioxidant defenses. In addition to the reduction in antioxidant capabilities, it is possible that a pro-oxidant pathway capable of increasing ROS production is also unveiled under these conditions.
In the present study, treating MCA from high-salt-fed SS-13BN consomic rats with the CYP4A inhibitor DDMS to reduce 20-HETE production fully restored the response to ACh to NS-fed control values, similar to the effects of restoring normal plasma ANG II levels. Taken together, these findings suggest that either two independent mechanisms lead to impaired vascular relaxation in HS-fed SS-13BN rats or that there is a potential interaction between these two pathways. One possibility is a role of circulating ANG II in the regulation of the CYP4A/20-HETE pathway by stimulating CYP4A enzyme activity to increase 20-HETE production. If this direct connection does not exist, there must be a separate mechanism for the CYP4A/20-HETE pathway to play a role in the vascular dysfunction with high-salt diet or in an ANG II-suppressed state.
Even though the CYP4A/20-HETE pathway appears to be contributing to vascular dysfunction in high-salt-fed SS-13BN consomic rats, there was no significant difference in 20-HETE production in the cerebral arteries of NS- and HS-fed SS-13BN rats in the present study. It is possible to affect the CYP4A/20-HETE pathway by altering the expression of individual CYP4A isoforms, having different catalytic efficiencies to form 20-HETE. The measurement of 20-HETE production in cerebral resistance arteries, however, argues against this possibility because there was no significant difference in the amount of 20-HETE produced in cerebral arteries from SS-13BN consomic rats fed either a normal-salt or a high-salt diet. As such, these data do not support a role for salt-induced ANG II suppression in directly regulating the CYP4A/20-HETE pathway.
As mentioned previously, the use of consomic animals has limitations due to the genetic material carried on chromosome 13 in addition to the renin allele. Thus, it is possible that other genes or gene regulators accompanying the renin gene on chromosome 13 exert a functional impact on the CYP4A/20-HETE pathway. In order to confirm our findings, we evaluated the direct effect of plasma ANG II on the CYP4A/20-HETE system by repeating our vascular studies in MCA from ANG II-infused SS rats. In these studies, supplementing circulating ANG II in the low-renin SS rat restored vascular relaxation responses, providing another example of the pervasive deleterious effect of suppressed ANG II on vascular function. The MCA from saline-treated SS rats failed to respond to ACh in control conditions. However, inhibition of CYP4A enzyme activity fully restored endothelium-dependent vasodilation in response to ACh in those animals. From those data, it appears that suppressed plasma ANG II in saline-treated SS rats (similar to high-salt-fed SS-13BN consomic rats), unveils a CYP4A/20-HETE effect on vascular function that is not observed when normal physiological levels of angiotensin II are maintained via an osmotic minipump.
20-HETE production in cerebral arteries from SS rats with minipump implantation showed no effect of ANG II on the CYP4A/20-HETE pathway itself. Considering the consistency between the ANG II-infused SS rat data and our findings in the SS-13BN consomic rat, it is reasonable to conclude that alterations in circulating ANG II levels do not have a direct regulatory effect on the CYP4A/20-HETE pathway in the SS rat, but instead both pathways have independent influences on vascular function. Thus, the effects of salt on the CYP4A/20-HETE pathway previously observed in S-D rats [21] seem to be either altered or nonexistent in the SS rat.
Vascular reactive oxygen species significantly contribute to vascular dysfunction in the SS rat [18,19]. The MCA from SS rats treated chronically with the superoxide dismutase mimetic tempol in the drinking water showed healthy vascular relaxation responses to acetylcholine and reduced PO2 regardless of dietary salt intake [18,19]. These findings indicate that ROS contribute to endothelial dysfunction in the SS rat fed either a normal-salt diet or high-salt diet. In the S-D rat, a high-salt diet stimulates ROS production and high-salt-induced ANG II suppression results in lowered Cu/Zn-SOD expression, thereby compromising antioxidant defense mechanisms and further elevating ROS levels [10,28]. CYP450-4A enzymes also have the capacity to produce superoxide anions (O2−) through their normal catalytic activity [29,30], via stimulation of NADPH oxidase [31,32,33,34], and by directly uncoupling endothelial nitric oxide synthase (eNOS), resulting in production of O2− instead of nitric oxide [35,36].
For these reasons, it is likely that the common factor between the HS-fed S-D rat and the low-renin SS rat is an elevation of ROS and not, as we had predicted, a direct effect of the renin–angiotensin system on the CYP4A/20-HETE pathway. Indeed, direct evaluation of ROS in basilar arteries from both NS-fed SS-13BN consomic rats and ANG II-infused Dahl SS rats showed significantly lower levels of vascular ROS than in their counterparts with suppressed plasma ANG II levels. Furthermore, incubating arteries from HS-fed SS-13BN consomic rats and saline-infused Dahl SS rats with the CYP4A inhibitor DDMS significantly reduced vascular ROS, to the same extent as restoring normal circulating ANG II levels, suggesting that both pathways influence vascular oxidative stress. Taken together, the current findings demonstrate an interesting model whereby two independent pathways affect vascular function similarly through a common mechanism.

5. Conclusions

Previous studies in our laboratory have shown that both the renin–angiotensin system and the CYP4A/20-HETE pathway play a role in the vascular dysfunction in the Dahl salt-sensitive rat. This study demonstrated that normalization of circulating ANG II levels or inhibition the CYP4A/20-HETE pathway restores vascular function in this animal model. The novel finding from this research is that these two pathways appear to influence vascular function independent of each other while sharing the common mechanism of generating vascular oxidative stress.

Author Contributions

Conceptualization, K.L. and J.L.; methodology, K.L. and J.L.; investigation, K.L.; resources, J.L. and J.R.F.; data curation, K.L.; writing—original draft preparation, K.L.; writing—review and editing, J.L. and J.R.F.; supervision, J.L.; project administration, K.L.; funding acquisition, J.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by NIH #HL-65289, #HL-72920, and #HL-092026.

Institutional Review Board Statement

The animal study protocol was approved by the Institutional Animal Care and Use Committee (IACUC) of the Medical College of Wisconsin. The approval code for these studies is AUA00002080.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author, J.L., upon reasonable request.

Acknowledgments

The authors thank Lynn Dondlinger and Brian Weinberg for their outstanding technical assistance.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Preston, R.A.; Materson, B.J.; Reda, D.J.; Williams, D.W.; Hamburger, R.J.; Cushman, W.C.; Anderson, R.J. Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. JAMA 1998, 280, 1168–1172. [Google Scholar] [CrossRef] [Green Version]
  2. Price, D.A.; Fisher, N.D. The renin-angiotensin system in blacks: Active, passive, or what? Curr. Hypertens. Rep. 2003, 5, 225–230. [Google Scholar] [CrossRef]
  3. Mackenzie, I.S.; Brown, M.J. Molecular and clinical investigations in patients with low-renin hypertension. Clin. Exp. Nephrol. 2009, 13, 1–8. [Google Scholar] [CrossRef]
  4. Helmer, O.M.; Judson, W.E. Metabolic studies on hypertensive patients with suppressed plasma renin activity not due to hyperaldosternosm. Circulation 1968, 38, 965–976. [Google Scholar] [CrossRef] [Green Version]
  5. Rapp, J.P.; Wang, S.M.; Dene, H. A genetic polymorphism in the renin gene of Dahl rats cosegregates with blood pressure. Science 1989, 243, 542–544. [Google Scholar] [CrossRef]
  6. Rapp, J.P.; McPartland, R.P.; Sustarsic, D.L. A qualitative difference in plasma renin activity in Dahl rats susceptible or resistant to salt-induced hypertension. Biochem. Genet. 1980, 18, 1087–1096. [Google Scholar] [CrossRef]
  7. Weber, D.S.; Lombard, J.H. Angiotensin II AT1 receptors preserve vasodilator reactivity in skeletal muscle resistance arteries. Am. J. Physiol. Heart Circ. Physiol. 2001, 280, H2196–H2202. [Google Scholar] [CrossRef] [Green Version]
  8. Weber, D.S.; Lombard, J.H. Elevated salt intake impairs dilation of rat skeletal muscle resistance arteries via ANG II suppression. Am. J. Physiol. Heart Circ. Physiol. 2000, 278, H500–H506. [Google Scholar] [CrossRef]
  9. Lombard, J.H.; Sylvester, F.A.; Phillips, S.A.; Frisbee, J.C. High-salt diet impairs vascular relaxation mechanisms in rat middle cerebral arteries. Am. J. Physiol. Heart Circ. Physiol. 2003, 284, H1124–H1133. [Google Scholar] [CrossRef] [Green Version]
  10. Zhu, J.; Huang, T.; Lombard, J.H. Effect of high-salt diet on vascular relaxation and oxidative stress in mesenteric resistance arteries. J. Vasc. Res. 2007, 44, 382–390. [Google Scholar] [CrossRef]
  11. Zhu, J.; Mori, T.; Huang, T.; Lombard, J.H. Effect of high-salt diet on NO release and superoxide production in rat aorta. Am. J. Physiol. Heart Circ. Physiol. 2004, 286, H575–H583. [Google Scholar] [CrossRef] [PubMed]
  12. Zhu, J.; Drenjancevic-Peric, I.; McEwen, S.; Friesema, J.; Schulta, D.; Yu, M.; Roman, R.J.; Lombard, J.H. Role of superoxide and angiotensin II suppression in salt-induced changes in endothelial Ca2+ signaling and NO production in rat aorta. Am. J. Physiol. Heart Circ. Physiol. 2006, 291, H929–H938. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Durand, M.J.; Lombard, J.H. Low-dose angiotensin II infusion restores vascular function in cerebral arteries of high salt-fed rats by increasing copper/zinc superoxide dimutase expression. Am. J. Hypertens. 2013, 26, 739–747. [Google Scholar] [CrossRef] [PubMed]
  14. Lukaszewicz, K.M.; Lombard, J.H. Role of the CYP4A/20-HETE pathway in vascular dysfunction of the Dahl salt-sensitive rat. Clin. Sci. 2013, 124, 695–700. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Durand, M.J.; Lombard, J.H. Introgression of the Brown Norway renin allele onto the Dahl salt-sensitive genetic background increases Cu/Zn SOD expression in cerebral arteries. Am. J. Hypertens. 2011, 24, 563–568. [Google Scholar] [CrossRef]
  16. Cowley, A.W.; Roman, R.J.; Kaldunski, M.L.; Dumas, P.; Dickhout, J.G.; Greene, A.S.; Jacob, H.J. Brown Norway chromosome 13 confers protection from high salt to consomic Dahl S rat. Hypertension 2001, 37, 456–461. [Google Scholar] [CrossRef] [Green Version]
  17. Drenjancevic-Peric, I.; Lombard, J.H. Introgression of chromosome 13 in Dahl salt-sensitive genetic background restores cerebral vascular relaxation. Am. J. Physiol. Heart Circ. Physiol. 2004, 287, H957–H962. [Google Scholar] [CrossRef] [Green Version]
  18. Durand, M.J.; Moreno, C.; Greene, A.S.; Lombard, J.H. Impaired Relaxation of Cerebral Arteries in the Absence of Elevated Salt Intake in Normotensive Congenic Rats Carrying the Dahl Salt-Sensitive Renin Gene. Am. J. Physiol. Heart Circ. Physiol. 2010, 299, H1865–H1874. [Google Scholar] [CrossRef]
  19. Drenjancevic-Peric, I.; Lombard, J.H. Reduced angiotensin II and oxidative stress contribute to impaired vasodilation in Dahl salt-sensitive rats on low-salt diet. Hypertension 2005, 45, 687–691. [Google Scholar] [CrossRef] [Green Version]
  20. Mattson, D.L.; Dwinell, M.R.; Greene, A.S.; Kwitek, A.E.; Roman, R.J.; Jacob, H.J.; Cowley, A.W., Jr. Chromosome substitution reveals the genetic basis of Dahl salt-sensitive hypertension and renal disease. Am. J. Physiol. Renal Physiol. 2008, 295, F837–F842. [Google Scholar] [CrossRef] [Green Version]
  21. Wang, J.; Roman, R.J.; Falck, J.R.; de la Cruz, L.; Lombard, J.H. Effects of high-salt diet on CYP450-4A omega-hydroxylase expression and active tone in mesenteric resistance arteries. Am. J. Physiol. Heart Circ. Physiol. 2005, 288, H1557–H1565. [Google Scholar] [CrossRef]
  22. Wang, J.; Schmidt, J.R.; Roman, R.J.; Anjaiah, S.; Falck, J.R.; Lombard, J.H. Modulation of vascular O2 responses by cytochrome 450-4A omega-hydroxylase metabolites in Dahl salt-sensitive rats. Microcirculation 2009, 16, 345–354. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Matic, A.; Jukic, I.; Mihaljevic, Z.; Kolobaric, N.; Stupin, A.; Kozina, N.; Bujak, I.T.; Kibel, A.; Lombard, J.H.; Drenjancevic, I. Low-dose angiotensin II supplementation restores flow-induced dilation mechanisms in cerebral arteries of Sprague-Dawley rats on a high salt diet. J. Hypertens. 2022, 40, 441–452. [Google Scholar] [CrossRef] [PubMed]
  24. Fredricks, K.T.; Liu, Y.; Lombard, J.H. Response of extraparenchymal resistance arteries of rat skeletal muscle to reduced PO2. Am. J. Physiol. 1994, 267, H706–H715. [Google Scholar] [CrossRef]
  25. Dunn, K.M.; Renic, M.; Flasch, A.K.; Harder, D.R.; Falck, J.; Roman, R.J. Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 2008, 295, H2455–H2465. [Google Scholar] [CrossRef] [Green Version]
  26. Drenjancevic-Peric, I.; Frisbee, J.C.; Lombard, J.H. Skeletal muscle arteriolar reactivity in SS.BN13 consomic rats and Dahl salt-sensitive rats. Hypertension 2003, 41, 1012–1015. [Google Scholar] [CrossRef] [Green Version]
  27. Drenjancevic-Peric, I.; Phillips, S.A.; Falck, J.R.; Lombard, J.H. Restoration of normal vascular relaxation mechanisms in cerebral arteries by chromosomal substitution in consomic SS.S.13BN rats. Am. J. Physiol. Heart Circ. Physiol. 2005, 289, H188–H195. [Google Scholar] [CrossRef]
  28. McEwen, S.T.; Schmidt, J.R.; Somberg, L.; Cruz Lde, L.; Lombard, J.H. Time-course and mechanisms of restored vascular relaxation by reduced salt intake and angiotensin II infusion in rats fed a high-salt diet. Microcirculation 2009, 16, 220–234. [Google Scholar] [CrossRef]
  29. Puntarulo, S.; Cederbaum, A.I. Production of reactive oxygen species by microsomes enriched in specific human cytochrome P450 enzymes. Free Radic. Biol. Med. 1998, 24, 1324–1330. [Google Scholar] [CrossRef]
  30. Bondy, S.C.; Naderi, S. Contribution of hepatic cytochrome P450 systems to the generation of reactive oxygen species. Biochem. Pharmacol. 1994, 48, 155–159. [Google Scholar] [CrossRef] [Green Version]
  31. Eid, A.A.; Gorin, Y.; Fagg, B.M.; Maalouf, R.; Barnes, J.L.; Block, K.; Abboud, H.E. Mechanisms of podocyte injury in diabetes: Role of cytochrome P450 and NADPH oxidases. Diabetes 2009, 58, 1201–1211. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Hama-Tomioka, K.; Kinoshita, H.; Azma, T.; Nakahata, K.; Matsuda, N.; Hatakeyama, N.; Kikuchi, H.; Hatano, Y. The role of 20-hydroxyeicosatetraenoic acid in cerebral arteriolar constriction and the inhibitory effect of propofol. Anesth. Analg. 2009, 109, 1935–1942. [Google Scholar] [CrossRef] [PubMed]
  33. Zeng, Q.; Han, Y.; Bao, Y.; Li, W.; Li, X.; Shen, X.; Wang, X.; Yao, F.; O’Rourke, S.T.; Sun, C. 20-HETE increases NADPH oxidase-derived ROS production and stimulates the L-type Ca2+ channel via a PKC-dependent mechanism in cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 2010, 299, H1109–H1117. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Singh, H.; Cheng, J.; Deng, H.; Kemp, R.; Ishizuka, T.; Nasjletti, A.; Schwartzman, M.L. Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis con.ntribute to endothelial dysfunction in androgen-induced hypertension. Hypertension 2007, 50, 123–129. [Google Scholar] [CrossRef] [Green Version]
  35. Cheng, J.; Ou, J.S.; Singh, H.; Falck, J.R.; Narsimhaswamy, D.; Pritchard, K.A., Jr.; Schwartzman, M.L. 20-hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling. Am. J. Physiol. Heart Circ. Physiol. 2008, 294, H1018–H1026. [Google Scholar] [CrossRef] [Green Version]
  36. Ward, N.C.; Chen, K.; Li, C.; Croft, K.D.; Keaney, J.F., Jr. Chronic activation of AMP-activated protein kinase prevents 20-hydroxyeicosatetraenoic acid-induced endothelial dysfunction. Clin. Exp. Pharmacol. Physiol. 2011, 38, 328–333. [Google Scholar] [CrossRef] [Green Version]
Antioxidants 12 00783 g001 550
Figure 1. Response of isolated middle cerebral arteries of SS-13BN consomic rats fed normal-salt (NS) diet or high-salt (HS) diet to: (A) acetylcholine (ACh; 10−10–10−5 M) ± acute addition of 50 µM DDMS; (B) ACh ± DDMS (50 µM) and ±L-NAME (100 µM) or indomethacin (INDO; 1 µM); and (C), sodium 50 µM nitroprusside (10−12–10−4 M) ± acute addition of DDMS (50 µM) to the tissue bath. Data are expressed as mean change in diameter (µm) from baseline ± SEM and n = 4–8 for all groups. Significant difference: * p < 0.05 vs. arteries from HS-fed SS-13BN consomic rats, † p < 0.05 vs. L-NAME-treated vessels.
Figure 1. Response of isolated middle cerebral arteries of SS-13BN consomic rats fed normal-salt (NS) diet or high-salt (HS) diet to: (A) acetylcholine (ACh; 10−10–10−5 M) ± acute addition of 50 µM DDMS; (B) ACh ± DDMS (50 µM) and ±L-NAME (100 µM) or indomethacin (INDO; 1 µM); and (C), sodium 50 µM nitroprusside (10−12–10−4 M) ± acute addition of DDMS (50 µM) to the tissue bath. Data are expressed as mean change in diameter (µm) from baseline ± SEM and n = 4–8 for all groups. Significant difference: * p < 0.05 vs. arteries from HS-fed SS-13BN consomic rats, † p < 0.05 vs. L-NAME-treated vessels.
Antioxidants 12 00783 g001
Antioxidants 12 00783 g002 550
Figure 2. Response of isolated middle cerebral arteries of SS rats fed high-salt diet and receiving infusion of either isotonic saline or angiotensin II (ANG II; 100 ng/kg/min) from an osmotic minipump to: (A) acetylcholine (ACh; 10−10–10−5 M) ± acute addition of DDMS (50 µM); (B); ACh ± DDMS (50 µM) and/or ±L-NAME (100 µM) or indomethacin (INDO; 1 µM); and (C) sodium nitroprusside (10−12–10−4 M) ± acute addition of DDMS (50 µM) to the tissue bath. Data are expressed as mean change in diameter (µm) from baseline ± SEM, and n = 6–8 for all groups. Significant difference: * p < 0.05 vs. saline-infused SS rats, † p < 0.05 vs. L-NAME-treated vessels, ‡ p < 0.05 vs. saline-infused SS ± DDMS at the 10−5 M dose.
Figure 2. Response of isolated middle cerebral arteries of SS rats fed high-salt diet and receiving infusion of either isotonic saline or angiotensin II (ANG II; 100 ng/kg/min) from an osmotic minipump to: (A) acetylcholine (ACh; 10−10–10−5 M) ± acute addition of DDMS (50 µM); (B); ACh ± DDMS (50 µM) and/or ±L-NAME (100 µM) or indomethacin (INDO; 1 µM); and (C) sodium nitroprusside (10−12–10−4 M) ± acute addition of DDMS (50 µM) to the tissue bath. Data are expressed as mean change in diameter (µm) from baseline ± SEM, and n = 6–8 for all groups. Significant difference: * p < 0.05 vs. saline-infused SS rats, † p < 0.05 vs. L-NAME-treated vessels, ‡ p < 0.05 vs. saline-infused SS ± DDMS at the 10−5 M dose.
Antioxidants 12 00783 g002
Antioxidants 12 00783 g003 550
Figure 3. 20-HETE production in cerebral arteries from (A) normal-salt (NS)- and high-salt (HS)-fed SS-13BN consomic rats and (B) SS rats fed high-salt diet with minipump delivery of either isotonic saline or angiotensin II (ANG II; 100 ng/kg/min). 20-HETE production assessed via LC-MS (n = 4–5 for all groups). Data are presented as amount of 20-HETE (pg) produced per minute per mg of protein.
Figure 3. 20-HETE production in cerebral arteries from (A) normal-salt (NS)- and high-salt (HS)-fed SS-13BN consomic rats and (B) SS rats fed high-salt diet with minipump delivery of either isotonic saline or angiotensin II (ANG II; 100 ng/kg/min). 20-HETE production assessed via LC-MS (n = 4–5 for all groups). Data are presented as amount of 20-HETE (pg) produced per minute per mg of protein.
Antioxidants 12 00783 g003
Antioxidants 12 00783 g004 550
Figure 4. Vascular reactive oxygen species evaluated by DHE fluorescence in basilar arteries of normal-salt (NS)- and high-salt (HS)-fed SS-13BN consomic rats in either control conditions or incubated with DDMS (n = 4–5 for all groups). Data are presented as % of DHE fluorescence (raw fluorescence units) in basilar arteries from NS-fed SS-13BN rats. * p < 0.05, significantly different from HS-fed SS-13BN; † p < 0.05, significantly different from NS-fed SS-13BN ± DDMS.
Figure 4. Vascular reactive oxygen species evaluated by DHE fluorescence in basilar arteries of normal-salt (NS)- and high-salt (HS)-fed SS-13BN consomic rats in either control conditions or incubated with DDMS (n = 4–5 for all groups). Data are presented as % of DHE fluorescence (raw fluorescence units) in basilar arteries from NS-fed SS-13BN rats. * p < 0.05, significantly different from HS-fed SS-13BN; † p < 0.05, significantly different from NS-fed SS-13BN ± DDMS.
Antioxidants 12 00783 g004
Table
Table 1. MCA Diameters and Resting Tone in SS-13BN Consomic Rats.
Table 1. MCA Diameters and Resting Tone in SS-13BN Consomic Rats.
Experimental GroupsNumber (n)Max Diameter
(µm)		Rest Diameter (µm)Active Tone (%)
SS-13BN 1 NS 26236 ± 2.0137 ± 4.742 ± 2.1
SS-13BN HS 36245 ± 3.9149 ± 3.339 ± 2.0
SS-13BN NS + DDMS 46237 ± 2.0140 ± 6.040 ± 4.7
SS-13BN HS + DDMS6245 ± 3.9133 ± 5.1645 ± 2.9
SS-13BN NS + L-NAME 56246 ± 5.9120 ± 10.151 ± 3.6
SS-13BN HS + DDMS + L-NAME6247 ± 4.7134 ± 6.345 ± 2.3
SS-13BN NS + INDO 64257 ± 8.5147 ± 14.645 ± 7.5
SS-13BN HS + DDMS + INDO4239 ± 3.6150 ± 7.337 ± 3.4
Data are summarized as mean ± SEM. 1 SS-13BN: SS-Chr 13BN/Mcw, 2 NS: Normal-salt (0.4% NaCl), 3 HS: High-salt (4% NaCl), 4 DDMS: N-methylsulfonyl-12,12-dibromododec-11-enamide, 5 L-NAME: Nω-nitro-L-arginine methyl ester, 6 INDO: Indomethacin.
Table
Table 2. MCA Diameters and Resting Tone in Dahl SS Rats with Minipump.
Table 2. MCA Diameters and Resting Tone in Dahl SS Rats with Minipump.
Experimental GroupsNumber (n)Max Diameter
(µm)		Rest Diameter (µm)Active Tone (%)
SS 1 + ANG II 28231 ± 2.6135 ± 2.042 ± 1.3
SS + Saline8235 ± 3.4141 ± 3.240 ± 1.8
SS + ANG II + DDMS 38231 ± 2.6145 ± 4.937 ± 2.5
SS + Saline + DDMS8235 ± 3.4142 ± 5.240 ± 2.7
SS + ANG II + L-NAME 46240 ± 3.9115 ± 5.4 *52 ± 2.4
SS + Saline + DDMS + L-NAME6240 ± 4.0125 ± 5.048 ± 2.0
SS + ANG II + INDO 53248 ± 8.7151 ± 6.337 ± 1.7
SS + Saline + DDMS + INDO3236 ± 3.5138 ± 5.041 ± 2.3
Data are summarized as mean ± SEM. 1 SS: Dahl SS, 2 ANG II: angiotensin II, 3 DDMS: N-methylsulfonyl-12,12-dibromododec-11-enamide, 4 L-NAME: Nω-nitro-L-arginine methyl ester, 5 INDO: indomethacin. * p < 0.05, significantly different from every treatment group within the same category.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Lukaszewicz, K.; Falck, J.R.; Lombard, J. Effect of Chronically Suppressed Plasma Angiotensin II on Regulation of the CYP4A/20-HETE Pathway in the Dahl Salt-Sensitive Rat. Antioxidants 2023, 12, 783. https://doi.org/10.3390/antiox12040783

AMA Style

Lukaszewicz K, Falck JR, Lombard J. Effect of Chronically Suppressed Plasma Angiotensin II on Regulation of the CYP4A/20-HETE Pathway in the Dahl Salt-Sensitive Rat. Antioxidants. 2023; 12(4):783. https://doi.org/10.3390/antiox12040783

Chicago/Turabian Style

Lukaszewicz, Kathleen, John R. Falck, and Julian Lombard. 2023. "Effect of Chronically Suppressed Plasma Angiotensin II on Regulation of the CYP4A/20-HETE Pathway in the Dahl Salt-Sensitive Rat" Antioxidants 12, no. 4: 783. https://doi.org/10.3390/antiox12040783

APA Style

Lukaszewicz, K., Falck, J. R., & Lombard, J. (2023). Effect of Chronically Suppressed Plasma Angiotensin II on Regulation of the CYP4A/20-HETE Pathway in the Dahl Salt-Sensitive Rat. Antioxidants, 12(4), 783. https://doi.org/10.3390/antiox12040783

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop